[Pharmacology of neuroprotection in acute ischemic stroke].

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Revista de neurología (Ed. impresa)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18780272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].

  2008cited by this paper
• Recommendations and treatment strategies for the management of acute ischemic stroke

  2008cited by this paper
• [Preadmission use of statins as treatment for strokes].

  2007cited by this paper
• Update on the treatment of spinal cord injury.

  2007cited by this paper
• [Statins and brain protection mechanisms].

  2007cited by this paper
• Prior Statin Use May Be Associated With Improved Stroke Outcome After Tissue Plasminogen Activator

  2007cited by this paper
• Stroke pathophysiology: management challenges and new treatment advances

  2007cited by this paper
• Reactive Oxygen Species and p38 Mitogen-Activated Protein Kinase Activate Bax to Induce Mitochondrial Cytochrome c Release and Apoptosis in Response to Malonate

  2007cited by this paper
• Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neurons

  2007cited by this paper
• [Statins and cerebrovascular disease: new perspectives in stroke prevention].

  2007cited by this paper
• Excitotoxic and excitoprotective mechanisms

  2007cited by this paper
• Albumin therapy in acute stroke patients

  2007cited by this paper
• Minocycline treatment in acute stroke

  2007cited by this paper
• Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone

  2006cited by this paper
• High-dose atorvastatin after stroke or transient ischemic attack.

  2006cited by this paper
• The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—II: Neurologic Outcome and Efficacy Analysis

  2006cited by this paper
• The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—I: Physiological Responses and Safety Results

  2006cited by this paper
• Safety and tolerability of arundic acid in acute ischemic stroke.

  2006cited by this paper
• Neuroprotection targets after traumatic brain injury

  2006cited by this paper
• The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.

  2005cited by this paper
• The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

  2005cited by this paper
• Effect of glutathione peroxidase mimic ebselen (PZ51) on endothelium and vascular structure of stroke‐prone spontaneously hypertensive rats

  2005cited by this paper
• Multitargeted Effects of Statin-Enhanced Thrombolytic Therapy for Stroke With Recombinant Human Tissue-Type Plasminogen Activator in the Rat

  2005cited by this paper
• Neuroprotection in brain and spinal cord trauma

  2005cited by this paper
• Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions.

  2005cited by this paper
• Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.

  2004cited by this paper
• Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis

  2004cited by this paper
• Rising statin use and effect on ischemic stroke outcome

  2004cited by this paper
• [The role of protein p53 in neurodegenerative processes throughout the 25 years of its history].

  2004cited by this paper
• p53: Twenty five years understanding the mechanism of genome protection

  2004cited by this paper
• Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology

  2004cited by this paper
• Mitochondrial control of neuron death and its role in neurodegenerative disorders

  2003cited by this paper
• Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage

  2003cited by this paper
• HMG-CoA Reductase Inhibitor Has Protective Effects Against Stroke Events in Stroke-Prone Spontaneously Hypertensive Rats

  2003cited by this paper
• Reactive oxygen species induce swelling and cytochrome c release but not transmembrane depolarization in isolated rat brain mitochondria

  2003cited by this paper
• Effect of Paracetamol (Acetaminophen) on Body Temperature in Acute Ischemic Stroke: A Double-Blind, Randomized Phase II Clinical Trial

  2001cited by this paper
• A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.

  2001cited by this paper
• The ischaemic penumbra

  2001cited by this paper
• Ischemic Penumbra: Evidence From Functional Imaging in Man

  2000cited by this paper
• [Cysteine proteinase and neurodegeneration].

  2000cited by this paper
• Molecular mechanisms of ischemic neuronal injury.

  2000cited by this paper
• Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators.

  2000cited by this paper
• Recent progress in drug treatment for acute stroke

  1999cited by this paper
• Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.

  1998cited by this paper
• Are More Complex Study Designs Needed for Future Acute Stroke Trials?

  1998cited by this paper
• Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

  1998cited by this paper
• Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats.

  1997cited by this paper
• A randomized dose-response trial of citicoline in acute ischemic stroke patients

  1997cited by this paper
• Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest.

  1997cited by this paper
• The new language of cerebral ischemia.

  1997cited by this paper
• Calcium-related damage in ischemia.

  1996cited by this paper
• The effects of prolonged treatment with citicoline in temporary experimental focal ischemia.

  1996cited by this paper
• Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.

  1996cited by this paper
• Flunarizine in stroke treatment (FIST): a double‐blind, placebo‐controlled trial in Scandinavia and the Netherlands

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction.

  1995cited by this paper
• Mediators of Injury in Neurotrauma: Intracellular Signal Transduction and Gene Expression

  1995cited by this paper
• Calpain: new perspectives in molecular diversity and physiological‐pathological involvement

  1994cited by this paper
• Viability thresholds and the penumbra of focal ischemia

  1994cited by this paper
• Effect of Propentofylline on Regional Cerebral Glucose Metabolism in Acute Ischemic Stroke

  1993cited by this paper
• Changes in Extracellular Glutamate Concentration Produced in the Rat Striatum by Repeated Ischemia

  1992cited by this paper
• Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia.

  1991cited by this paper
• Cerebral hypoxia: some new approaches and unanswered questions

  1990cited by this paper
• Calmodulin-binding proteins as calpain substrates.

  1989cited by this paper
• Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy.

  1982cited by this paper
• Thresholds in cerebral ischemia - the ischemic penumbra.

  1981cited by this paper
• Changes in Extracellular Calcium Activity in Cerebral Ischaemia

  1981cited by this paper

• Asiatic acid and its derivatives: Pharmacological insights and applications.

  2025cites this paper
• Unveiling synergies: Integrating TCM herbal medicine and acupuncture with conventional approaches in stroke management.

  2024cites this paper
• Neuroprotection by Phytoestrogens in the Model of Deprivation and Resupply of Oxygen and Glucose In Vitro: The Contribution of Autophagy and Related Signaling Mechanisms

  2020cites this paper
• Análisis de factores asociados a la recuperación integral de pacientes de ictus al alta de hospital de agudos

  2020cites this paper
• Evaluación de la glicosilación tipo O-GlcNAc en el hipocampo de rata sometida a isquemia cerebral focal

  2017cites this paper
• A STUDY ON SERUM FIBRINOGEN LEVEL AND ITS PROGNOSTIC SIGNIFICANCE IN PATIENTS WITH ACUTE ISCHEMIC STROKE

  2016cites this paper
• [Atorvastatin-meloxicam association inhibits neuroinflammation and attenuates the cellular damage in cerebral ischemia by arterial embolism].

  2014cites this paper
• Neuroprotective role of total oligomeric flavonoids of Cyperus rotundus in rat model of transient focal ischemia

  2014cites this paper
• Review: Could neurotransmitters influence neurogenesis and neurorepair after stroke?

  2013cites this paper
• Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke.

  2013cites this paper
• [Brain repair after ischemic stroke: role of neurotransmitters in post-ischemic neurogenesis].

  2012cites this paper
• [The role played by Toll-like receptors in cerebral infarction processes].

  2011cites this paper
• Transient focal cerebral ischemia significantly alters not only EAATs but also VGLUTs expression in rats: relevance of changes in reactive astroglia

  2010cites this paper
• [Calcium transport mechanisms in neuroprotection and neurotoxicity].

  2010cites this paper
• [Inflammatory response during ischaemic processes: adhesion molecules and immunomodulation].

  2010cites this paper
• [Inflammation as a therapeutic agent in cerebral infarction: cellular inflammatory response and inflammatory mediators].

  2010cites this paper
• Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis.

  2010cites this paper
• [Matrix metaloproteinases in neurological brain lesions: a new therapeutic target?].

  2010cites this paper
• [Effect of intensive treatment with atorvastatin versus standard doses of statins on the risk of stroke. A meta-analysis from five randomized trials including 25,709 patients].

  2009cites this paper
• Different mechanisms of Ca2+ regulation that influence synaptic transmission: Comparison between crayfish and Drosophila neuromuscular junctions

  2009cites this paper
• [Lipoprotein-associated phospholipase A(2) and stroke].

  2009cites this paper
• [Arterial ischaemic stroke in children with cardiac diseases].

  2009cites this paper
• [Reorganisation of the cerebral vasculature following ischaemia].

  2009cites this paper
• THE INFLUENCE OF Ca2+ REGULATION IN SYNAPTIC FACILITATION OF MOTOR NERVE TERMINALS IN CRAYFISH AND DROSOPHILA AS WELL AS IN THE PHYSIOLOGICAL REGULATION OF LARVAL DROSOPHILA HEART

  2008cites this paper